Genomics Personalized Health Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global genomics personalized health market looks promising with opportunities in academics & research institutes and diagnostic centers. The global genomics personalized health market is expected to grow with a CAGR of 14%-16% from 2020 to 2025. The major drivers for this market are rising biopharmaceutical and healthcare industries, increasing prevalence of cancer, growing geriatric population, and development in technologies.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genomics personalized health market report, please download the report brochure.
In this market, NGS platform is the largest technology of genomics personalized health. Growth in various segments of the genomics personalized health market are given below:
The study includes trends and forecast for the global genomics personalized health market by test type, technology, end user, and region as follows:
By Test Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that NGS platforms will remain the largest technology segment over the forecast period, as it consists of prominent best-selling and advance sequencing products used for various genetic analysis and development of highly efficient technologies.
North America will remain the largest region over the forecast period due to increasing healthcare expenditure and growing pharmaceutical and biotechnology companies in the region.
Features of the Global Genomics Personalized Health Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global genomics personalized health market by test type (oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others), technology (NGS platforms, RT-PCR, microarray, genetic analyzers, and others), end user (academics & research institutes, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genomics personalized health market?
Q.5 What are the business risks and threats to the global genomics personalized health market?
Q.6 What are the emerging trends in this genomics personalized health market and the reasons behind them?
Q.7 What are some changing demands of customers in this genomics personalized health market?
Q.8 What are the new developments in this genomics personalized health market? Which companies are leading these developments?
Q.9 Who are the major players in this genomics personalized health market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this genomics personalized health market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global genomics personalized health market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others), Technology (NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others), and End User (Academics & Research Institutes, Diagnostic Centers, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global genomics personalized health market looks promising with opportunities in academics & research institutes and diagnostic centers. The global genomics personalized health market is expected to grow with a CAGR of 14%-16% from 2020 to 2025. The major drivers for this market are rising biopharmaceutical and healthcare industries, increasing prevalence of cancer, growing geriatric population, and development in technologies.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genomics personalized health market report, please download the report brochure.
In this market, NGS platform is the largest technology of genomics personalized health. Growth in various segments of the genomics personalized health market are given below:
The study includes trends and forecast for the global genomics personalized health market by test type, technology, end user, and region as follows:
By Test Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Oncology Testing
- Infectious Disease Testing
- Orphan Disease Testing
- Autoimmune Disease Testing
- Obstetrics Testing
- Others
- NGS (Next Generation Sequencing) Platforms
- RT-PCR (Real Time Polymerase Chain Reaction)
- Microarray
- Genetic Analyzers
- Others
- Academics & Research Institutes
- Diagnostic Centers
- Others
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that NGS platforms will remain the largest technology segment over the forecast period, as it consists of prominent best-selling and advance sequencing products used for various genetic analysis and development of highly efficient technologies.
North America will remain the largest region over the forecast period due to increasing healthcare expenditure and growing pharmaceutical and biotechnology companies in the region.
Features of the Global Genomics Personalized Health Market
- Market Size Estimates: Global genomics personalized health market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global genomics personalized health market size by various segments, such as test type, technology, and end user in terms of value.
- Regional Analysis: Global genomics personalized health market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different test type, technology, end user, and region for the global genomics personalized health market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global genomics personalized health market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global genomics personalized health market by test type (oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others), technology (NGS platforms, RT-PCR, microarray, genetic analyzers, and others), end user (academics & research institutes, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genomics personalized health market?
Q.5 What are the business risks and threats to the global genomics personalized health market?
Q.6 What are the emerging trends in this genomics personalized health market and the reasons behind them?
Q.7 What are some changing demands of customers in this genomics personalized health market?
Q.8 What are the new developments in this genomics personalized health market? Which companies are leading these developments?
Q.9 Who are the major players in this genomics personalized health market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this genomics personalized health market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global genomics personalized health market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others), Technology (NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others), and End User (Academics & Research Institutes, Diagnostic Centers, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genomics Personalized Health Market Trends and Forecast
3.3: Global Genomics Personalized Health Market by Test Type
3.3.1: Oncology Testing
3.3.2: Infectious Disease Testing
3.3.3: Orphan Disease Testing
3.3.4: Autoimmune Disease Testing
3.3.5: Obstetrics Testing
3.3.6: Others
3.4: Global Genomics Personalized Health Market by Technology
3.4.1: NGS (Next Generation Sequencing) Platforms
3.4.2: RT-PCR (Real Time Polymerase Chain Reaction)
3.4.3: Microarray
3.4.4: Genetic Analyzers
3.4.5: Others
3.5: Global Genomics Personalized Health Market by End User
3.5.1: Academics & Research Institutes
3.5.2: Diagnostic Centers
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Genomics Personalized Health Market by Region
4.2: North American Genomics Personalized Health Market
4.2.1: Market by Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others
4.2.2: Market by Technology: NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others
4.2.3: Market by End User: Academics & Research Institutes, Diagnostic Centers, and Others
4.2.4: The United States Genomics Personalized Health Market
4.2.5: The Canadian Genomics Personalized Health Market
4.2.6: The Mexican Genomics Personalized Health Market
4.3: European Genomics Personalized Health Market
4.3.1: Market by Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others
4.3.2: Market by Technology: NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others
4.3.3: Market by End User: Academics & Research Institutes, Diagnostic Centers, and Others
4.3.4: The Genomics Personalized Health Market of United Kingdom
4.3.5: The Spanish Genomics Personalized Health Market
4.3.6: The German Genomics Personalized Health Market
4.3.7: The French Genomics Personalized Health Market
4.4: APAC Genomics Personalized Health Market
4.4.1: Market by Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others
4.4.2: Market by Technology: NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others
4.4.3: Market by End User: Academics & Research Institutes, Diagnostic Centers, and Others
4.4.4: The Chinese Genomics Personalized Health Market
4.4.5: The Indian Genomics Personalized Health Market
4.4.6: The Japanese Genomics Personalized Health Market
4.5: ROW Genomics Personalized Health Market
4.5.1: Market by Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others
4.5.2: Market by Technology: NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others
4.5.3: Market by End User: Academics & Research Institutes, Diagnostic Centers, and Others
4.5.4: Brazilian Genomics Personalized Health Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genomics Personalized Health Market by Test Type
7.1.2: Growth Opportunities for the Global Genomics Personalized Health Market by Technology
7.1.3: Growth Opportunities for the Global Genomics Personalized Health Market by End User
7.1.4: Growth Opportunities for the Global Genomics Personalized Health Market by Region
7.2: Emerging Trends in the Global Genomics Personalized Health Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Genomics Personalized Health Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genomics Personalized Health Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Qiagen N.V.
8.2: Illumina, Inc.
8.3: Therm Fisher Scientific, Inc.
8.4: Bio-Rad Laboratories, Inc.
8.5: F. Hoffmann-La Roche Ltd.
8.6: Lonza Group Ltd.
8.7: Invitae Corporation
8.8: Genetic Technologies Limited
8.9: Eastern Biotech
8.10: DNA Genotek Inc.
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genomics Personalized Health Market Trends and Forecast
3.3: Global Genomics Personalized Health Market by Test Type
3.3.1: Oncology Testing
3.3.2: Infectious Disease Testing
3.3.3: Orphan Disease Testing
3.3.4: Autoimmune Disease Testing
3.3.5: Obstetrics Testing
3.3.6: Others
3.4: Global Genomics Personalized Health Market by Technology
3.4.1: NGS (Next Generation Sequencing) Platforms
3.4.2: RT-PCR (Real Time Polymerase Chain Reaction)
3.4.3: Microarray
3.4.4: Genetic Analyzers
3.4.5: Others
3.5: Global Genomics Personalized Health Market by End User
3.5.1: Academics & Research Institutes
3.5.2: Diagnostic Centers
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Genomics Personalized Health Market by Region
4.2: North American Genomics Personalized Health Market
4.2.1: Market by Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others
4.2.2: Market by Technology: NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others
4.2.3: Market by End User: Academics & Research Institutes, Diagnostic Centers, and Others
4.2.4: The United States Genomics Personalized Health Market
4.2.5: The Canadian Genomics Personalized Health Market
4.2.6: The Mexican Genomics Personalized Health Market
4.3: European Genomics Personalized Health Market
4.3.1: Market by Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others
4.3.2: Market by Technology: NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others
4.3.3: Market by End User: Academics & Research Institutes, Diagnostic Centers, and Others
4.3.4: The Genomics Personalized Health Market of United Kingdom
4.3.5: The Spanish Genomics Personalized Health Market
4.3.6: The German Genomics Personalized Health Market
4.3.7: The French Genomics Personalized Health Market
4.4: APAC Genomics Personalized Health Market
4.4.1: Market by Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others
4.4.2: Market by Technology: NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others
4.4.3: Market by End User: Academics & Research Institutes, Diagnostic Centers, and Others
4.4.4: The Chinese Genomics Personalized Health Market
4.4.5: The Indian Genomics Personalized Health Market
4.4.6: The Japanese Genomics Personalized Health Market
4.5: ROW Genomics Personalized Health Market
4.5.1: Market by Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others
4.5.2: Market by Technology: NGS Platforms, RT-PCR, Microarray, Genetic Analyzers, and Others
4.5.3: Market by End User: Academics & Research Institutes, Diagnostic Centers, and Others
4.5.4: Brazilian Genomics Personalized Health Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genomics Personalized Health Market by Test Type
7.1.2: Growth Opportunities for the Global Genomics Personalized Health Market by Technology
7.1.3: Growth Opportunities for the Global Genomics Personalized Health Market by End User
7.1.4: Growth Opportunities for the Global Genomics Personalized Health Market by Region
7.2: Emerging Trends in the Global Genomics Personalized Health Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Genomics Personalized Health Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genomics Personalized Health Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Qiagen N.V.
8.2: Illumina, Inc.
8.3: Therm Fisher Scientific, Inc.
8.4: Bio-Rad Laboratories, Inc.
8.5: F. Hoffmann-La Roche Ltd.
8.6: Lonza Group Ltd.
8.7: Invitae Corporation
8.8: Genetic Technologies Limited
8.9: Eastern Biotech
8.10: DNA Genotek Inc.
